Abstract:ABSTRACT The comparative effect of tuna oil (TO) and salmon oil (SO) on the plasma and liver lipid and fatty acid compositions in Sprague Dawley rats was investigated. The total triacylglycerol (TG) and total cholesterol (TC) concentrations in liver was significantly decreased in the TO group; TG level in liver was also significantly decreased in the SO group. The mRNA expression of HMG‐CoA reductase in liver was significantly down‐regulated in the TO and SO groups relative to the control group. The plasma TG and TC were decreased in TO, but not in SO; plasma low‐density lipoprotein and very low‐density lipoprotein levels in TO and SO were decreased compared with the control group. The total n‐3 polyunsaturated fatty acid (PUFA) in plasma and liver phospholipids was significantly elevated in the TO and SO. Docosahexaenoic acid (22:6n‐3) and eicosapentaenoic acid (20:5n‐3) in tissues were significantly increased in the TO and SO, respectively. In this study, TO had a more beneficial effect on liver TC and plasma TG, TC, high‐density lipoprotein in rats than SO. The likely mechanism for lowering liver and plasma cholesterol by n‐3 PUFA is to suppress the mRNA expression of gene encoding HMG‐CoA reductase responsible for cholesterol biosynthesis. PRACTICAL APPLICATIONSThe beneficial effects of n‐3 polyunsaturated fatty acids (PUFAs) from fish and fish oil on human health is derived from their role in modulating membrane lipid composition and affecting metabolic and signal‐transduction pathways. In the present study, we demonstrated that n‐3 PUFA, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) from tuna and salmon oils can be effectively incorporated into tissue membranes. Tuna oil rich in DHA has more beneficial effect on liver total cholesterol (TC) and plasma triglyceride, TC and HDL in rats than salmon oil, which is rich in EPA. The present data could provide information for the potential application of fish oils as components of functional food, and selected for fortiﬁcation with different fish oils.

Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism

Effect Of Polyunsaturated Fatty Acids On Homocysteine Metabolism Through Regulating The Gene Expressions Involved In Methionine Metabolism

Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism

Effects of Fish Oil with a High Content of n-3 Polyunsaturated Fatty Acids on Mouse Gut Microbiota

Comparative Effects of Tuna Oil and Salmon Oil on Liver Lipid Metabolism and Fatty Acid Concentrations in Rats

High consumption of omega-3 polyunsaturated fatty acids decrease plasma homocysteine: A meta-analysis of randomized, placebo-controlled trials

N-3 Polyunsaturated Fatty Acids Prevent the D-Galactose-induced Cognitive Impairment by Up-Regulating the Levels of 5-Hydroxymethylcytosine in the Mouse Brain

Nutriproteomics and Nutrigenomics: Exploring the Mechanism Behind Omega-3 Polyunsaturated Fatty Acids, Homocysteine and Glucose Metabolism

Omega-3 PUFA Ameliorates Hyperhomocysteinemia-Induced Hepatic Steatosis in Mice by Inhibiting Hepatic Ceramide Synthesis.

A Significant Inverse Relationship Between Concentrations of Plasma Homocysteine and Phospholipid Docosahexaenoic Acid in Healthy Male Subjects.

Effects of a Fish Oil Rich in Docosahexaenoic Acid on Cardiometabolic Risk Factors and Oxidative Stress in Healthy Rats

Effect of Vitamin B_12 and N-3 Polyunsaturated Fatty Acids on Plasma Homocysteine, Ferritin, C-Reaction Protein, and Other Cardiovascular Risk Factors: a Randomized Controlled Trial

Influence of the Degree of Unsaturation in Fish Oil Supplements on Oxidative Stress and Protein Carbonylation in the Cerebral Cortex and Cerebellum of Healthy Rats

[N-3 Polyunsaturated Fatty Acid Attenuates Hyperhomocysteinemia-Induced Hepatic Steatosis by Increasing Hepatic LXA5 Content].

DHA prevents altered 5-HT1A, 5-HT2A, CB1 and GABAA receptor binding densities in the brain of male rats fed a high-saturated-fat diet.

Docosahexaenoic Acid-Rich Fish Oil Alleviates Hepatic Steatosis in Association with Regulation of Gut Microbiome in Ob/ob Mice.

Ω-3 PUFAs Alleviate High-Fat Diet-Induced Circadian Intestinal Microbes Dysbiosis.

Integrated gut microbiome and metabolome analyses reveals an inconsistent dose effect of a tuna oil with more higher docosahexaenoic acid content on intestinal dysbiosis and metabolic disorders in high-fat diet-fed mice.

Fish Oil is More Potent Than Flaxseed Oil in Modulating Gut Microbiota and Reducing Trimethylamine-N-oxide-Exacerbated Atherogenesis.

Homocysteine downregulates gene expression of heme oxygenase-1 in hepatocytes

The effect of fish oil supplementation on brain DHA and EPA content and fatty acid profile in mice